Similar articles

• Recommendations from the ICM-VTE: Hip & Knee.

  The ICM-VTE Hip & Knee Delegates. The ICM-VTE Hip & Knee Delegates. J Bone Joint Surg Am. 2022 Mar 16;104(Suppl 1):180-231. doi: 10.2106/JBJS.21.01529. J Bone Joint Surg Am. 2022. PMID: 35315610 No abstract available.
• Erratum: Recommendations from the ICM-VTE: General.

  [No authors listed] [No authors listed] J Bone Joint Surg Am. 2022 Aug 3;104(15):e69. doi: 10.2106/JBJS.ER.21.01531. Epub 2022 Aug 3. J Bone Joint Surg Am. 2022. PMID: 35924953 No abstract available.
• Effect of post-discharge venous thromboembolism on hospital quality comparisons following hip and knee arthroplasty.

  Kester BS, Merkow RP, Ju MH, Peabody TD, Bentrem DJ, Ko CY, Bilimoria KY. Kester BS, et al. J Bone Joint Surg Am. 2014 Sep 3;96(17):1476-84. doi: 10.2106/JBJS.M.01248. J Bone Joint Surg Am. 2014. PMID: 25187587
• Clinical Effectiveness and Safety of Aspirin for Venous Thromboembolism Prophylaxis After Total Hip and Knee Replacement: A Systematic Review and Meta-analysis of Randomized Clinical Trials.

  Matharu GS, Kunutsor SK, Judge A, Blom AW, Whitehouse MR. Matharu GS, et al. JAMA Intern Med. 2020 Mar 1;180(3):376-384. doi: 10.1001/jamainternmed.2019.6108. JAMA Intern Med. 2020. PMID: 32011647 Free PMC article.
• Warfarin for venous thromboembolism prophylaxis after elective hip or knee arthroplasty: exploring the evidence, guidelines, and challenges remaining.

  Dager WE. Dager WE. Ann Pharmacother. 2012 Jan;46(1):79-88. doi: 10.1345/aph.1P626. Epub 2011 Dec 27. Ann Pharmacother. 2012. PMID: 22202495 Review.